Page last updated: 2024-09-04

16-fluoro-5-androsten-17-one and Cancer of Skin

16-fluoro-5-androsten-17-one has been researched along with Cancer of Skin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberts, DS; Boone, CW; Covey, JM; Crowell, JA; Doody, LA; Greenwald, P; Kelloff, GJ; Knapp, GG; Lubet, RA; Steele, VE1
Lewbart, ML; Pashko, LL; Schwartz, AG1

Other Studies

2 other study(ies) available for 16-fluoro-5-androsten-17-one and Cancer of Skin

ArticleYear
Clinical development plan: DHEA analog 8354.
    Journal of cellular biochemistry. Supplement, 1994, Volume: 20

    Topics: Androstenes; Animals; Antineoplastic Agents; Clinical Trials as Topic; Dogs; Drug Approval; Female; Humans; Male; Mice; Rats; Rats, Sprague-Dawley; Skin Neoplasms

1994
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides.
    Carcinogenesis, 1991, Volume: 12, Issue:11

    Topics: Androstenes; Animals; Body Weight; Deoxyribonucleosides; Drug Interactions; Female; Mice; Mice, Inbred Strains; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate

1991